K 8515
Latest Information Update: 27 Apr 2007
At a glance
- Originator Dow Chemical; Nonindustrial source; University of Michigan
- Developer Dow Chemical; Nonindustrial source
- Class
- Mechanism of Action Cholesterol inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hyperlipidaemia
Most Recent Events
- 15 Dec 1997 Phase-II clinical trials for Hyperlipidaemia in USA (Unknown route)
- 06 Oct 1994 Phase-I clinical trials for Hyperlipidaemia in USA (Unknown route)